1. Acts and Regulations - Canada.ca (2020). https://www.canada.ca/en/health-canada/corporate/about-health-canada/legislation-guidelines/acts-regulations.html. Accessed 19 May 2020
2. Australian Regulatory Guidelines for Prescription Medicines (ARGPM) | Therapeutic Goods Administration (TGA) (2020). https://www.tga.gov.au/publication/australian-regulatory-guidelines-prescription-medicines-argpm. Accessed 12 May 2020
3. Bhave A, Menon S (2019) Subject expert committees: past, present, and future. Perspect Clin Res 10:1–3
4. Camarero J, Ruiz S (2012) Cancer immunotherapy products: regulatory aspects in the European Union. Hum Vaccines Immunother 8:1354–1359
5. CDSCO (2020a) Requirements for permission of New Drugs Approval Post approval changes in biological products: Quality safety and Efficacy Documents Guidance for Industry.Central Drugs Standard Control Organisation, Ministry of Health G o. I (2012)